絞り込み

16643

広告

Prognosis of Small Cell Lung Cancer with Idiopathic Pulmonary Fibrosis: Assessment according to GAP Stage.

著者 Song MJ , Lim SY , Park JS , Yoon HI , Lee JH , Kim SY , Jung JY , Kang YA , Park MS , Kim YS , Chang J , Lee SH , Lee CT
J Oncol.2019 ; 2019():5437390.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (4view , 0users)

Full Text Sources

Idiopathic pulmonary fibrosis (IPF) is an independent risk factor for lung cancer development, and small cell lung cancer (SCLC) comprises 15-20% of lung cancers with IPF. The objective of this study was to investigate survival outcomes and treatment-related complications according to GAP (gender, age, and physiology) stage in patients having SCLC with IPF (SCLC-IPF).
PMID: 31186636 [PubMed]
印刷用ページを開く Endnote用テキストダウンロード